Treg Cell Therapy for T1D - of Mice and Man

Treg Cell Therapy for T1D - of Mice and Man

Wednesday, July 21, 2021
10:30 AM - 11:30 AM

Presenter: Qizhi Tang, PhD

Organization: University of California at San Francisco (UCSF)

Dr. Qizhi Tang is a professor in immunology and director of the UCSF Transplantation Research Laboratory.

One area of research in the Tang Lab focuses on investigating regulatory T cell control of autoimmune diseases and transplant rejection to guide rationalized design of Treg-based immunotherapeutics for immune tolerance.

Another area of research in the Tang Lab aims to develop renewable immunosuppression-free beta cell replacement therapy for the treatment of diabetes. 

Register now